BRPI0812772A2 - Método in vitro para a identificação de moléculas antigênicas transportadas por eritrócitos e/ou anticorpos anti-eritrocitários de um indivíduo, método para combinação cruzada de eritrócitos que devem ser transfundidos em um paciente e um conjunto de reagentes para a execução do método de detecção . - Google Patents

Método in vitro para a identificação de moléculas antigênicas transportadas por eritrócitos e/ou anticorpos anti-eritrocitários de um indivíduo, método para combinação cruzada de eritrócitos que devem ser transfundidos em um paciente e um conjunto de reagentes para a execução do método de detecção .

Info

Publication number
BRPI0812772A2
BRPI0812772A2 BRPI0812772-7A2A BRPI0812772A BRPI0812772A2 BR PI0812772 A2 BRPI0812772 A2 BR PI0812772A2 BR PI0812772 A BRPI0812772 A BR PI0812772A BR PI0812772 A2 BRPI0812772 A2 BR PI0812772A2
Authority
BR
Brazil
Prior art keywords
eythrogen
conductions
erythrocytes
muscle
individual
Prior art date
Application number
BRPI0812772-7A2A
Other languages
English (en)
Inventor
Frederic Buffiere
Amparo Sanjuan
Yves Raisin
Eliane Rivalin
Original Assignee
Bio Rad Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur filed Critical Bio Rad Pasteur
Publication of BRPI0812772A2 publication Critical patent/BRPI0812772A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI0812772-7A2A 2007-06-08 2008-06-06 Método in vitro para a identificação de moléculas antigênicas transportadas por eritrócitos e/ou anticorpos anti-eritrocitários de um indivíduo, método para combinação cruzada de eritrócitos que devem ser transfundidos em um paciente e um conjunto de reagentes para a execução do método de detecção . BRPI0812772A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0755624A FR2917174B1 (fr) 2007-06-08 2007-06-08 Analyse multiple d'echantillons sanguins
US92905207P 2007-06-11 2007-06-11
PCT/EP2008/057116 WO2008148886A1 (en) 2007-06-08 2008-06-06 Multiple analysis of blood samples

Publications (1)

Publication Number Publication Date
BRPI0812772A2 true BRPI0812772A2 (pt) 2014-12-02

Family

ID=38582044

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0812772-7A2A BRPI0812772A2 (pt) 2007-06-08 2008-06-06 Método in vitro para a identificação de moléculas antigênicas transportadas por eritrócitos e/ou anticorpos anti-eritrocitários de um indivíduo, método para combinação cruzada de eritrócitos que devem ser transfundidos em um paciente e um conjunto de reagentes para a execução do método de detecção .
BRPI0812770-0A2A BRPI0812770A2 (pt) 2007-06-08 2008-06-06 Método in vitro para identificar uma pluralidade de moléculas antigênicas transportadas por eritrócitos de um indivíduo, e/ou identificar uma pluralidade de anticorpos contra moléculas antigênicas transportadas por eritrócitos, conjunto de reagentes para implementar o método de detecção .

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0812770-0A2A BRPI0812770A2 (pt) 2007-06-08 2008-06-06 Método in vitro para identificar uma pluralidade de moléculas antigênicas transportadas por eritrócitos de um indivíduo, e/ou identificar uma pluralidade de anticorpos contra moléculas antigênicas transportadas por eritrócitos, conjunto de reagentes para implementar o método de detecção .

Country Status (15)

Country Link
US (2) US8580531B2 (pt)
EP (2) EP2160609B1 (pt)
JP (2) JP5768371B2 (pt)
KR (2) KR101508699B1 (pt)
CN (2) CN101715558A (pt)
AU (2) AU2008258509B2 (pt)
BR (2) BRPI0812772A2 (pt)
CA (2) CA2687756A1 (pt)
EA (2) EA017380B1 (pt)
FR (1) FR2917174B1 (pt)
IL (2) IL202216A (pt)
MX (2) MX2009013411A (pt)
NZ (3) NZ581716A (pt)
WO (2) WO2008148890A1 (pt)
ZA (2) ZA201000093B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008034102A2 (en) * 2006-09-15 2008-03-20 Haemonetics Corporation Surface mapping by optical manipulation of particles in relation to a functionalized surface
FR2917174B1 (fr) * 2007-06-08 2021-02-12 Bio Rad Pasteur Analyse multiple d'echantillons sanguins
DE102009037331A1 (de) * 2009-08-14 2011-03-03 Pluriselect Gmbh Verfahren zur Separierung von Partikeln und/oder Zellen mit 2 und mehr Oberflächenspezifitäten
FR2963107B1 (fr) * 2010-07-21 2019-06-28 Diagast Complexe immuno-magnetique et son utilisation pour le groupage/phenotypage erythrocytaire
EP2670840A4 (en) * 2011-02-01 2015-08-19 Arryx Inc METHOD AND DEVICES FOR IMMUNDIAGNOSTIC APPLICATIONS
US9182389B2 (en) * 2011-02-22 2015-11-10 Chrome Red Technologies, Llc Detection of specific antigens in a population of antigens
US20140249051A1 (en) * 2011-08-30 2014-09-04 The Governors Of The University Of Alberta Method and system for abo antibody detection and characterization
WO2013083619A1 (en) 2011-12-06 2013-06-13 Universite Libre De Bruxelles Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes
CA2845674C (en) * 2011-12-21 2018-01-16 Grifols, S.A. Identification of atypical antibodies in human blood and blood products
FR2991689B1 (fr) * 2012-06-11 2018-04-20 Diagast Dispositif de diagnostic immuno-hematologique et utilisations
WO2013188756A1 (en) 2012-06-15 2013-12-19 The University Of Chicago Oligonucleotide-mediated quantitative multiplexed immunoassays
WO2014176535A1 (en) 2013-04-26 2014-10-30 Bio-Rad Laboratories, Inc. Multiplex hepatitis b assay
CN103344772B (zh) * 2013-07-19 2015-06-24 中国科学院苏州生物医学工程技术研究所 Miltenberger血型抗体检测新方法
CN103344755B (zh) * 2013-07-19 2015-06-24 中国科学院苏州生物医学工程技术研究所 一种磁化醛化羊红细胞的制备方法
CN104569376B (zh) * 2013-10-09 2017-11-10 常州博闻迪医药科技有限公司 一种磁微粒介导的层析检测技术装置及其用途
KR102047061B1 (ko) 2013-10-30 2019-11-20 서울대학교산학협력단 이중 표지 마이크로 디스크 및 그를 이용한 다중 검출방법
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use
JP6746059B2 (ja) 2015-01-14 2020-08-26 バイオ−ラッド ラボラトリーズ，インコーポレイティド 血液分析の系および方法
JP6692834B2 (ja) 2015-02-09 2020-05-13 スリングショット バイオサイエンシーズ， インコーポレイテッド 調整可能な光学特性を有するヒドロゲル粒子およびその使用の方法
EP3165920B1 (de) 2015-11-06 2019-07-03 imusyn GmbH & Co. KG Verfahren zur analyse von serum auf anti-erythrozytäre antikörper
CN105699667B (zh) * 2016-01-26 2018-01-09 北京中科圆融生物科技发展有限公司 细菌磁颗粒红细胞膜复合颗粒及其临床应用
WO2018187348A1 (en) * 2017-04-03 2018-10-11 Immucor, Inc. Red cell diluent with edta and methods for making and using the same
CN107643409B (zh) * 2017-09-19 2021-05-04 中国人民解放军总医院 一种血型抗原芯片及其在红细胞意外抗体检测中的应用
AU2019221625A1 (en) 2018-02-16 2020-08-13 Diagast In vitro diagnosis device comprising beads and uses thereof
CN109725144A (zh) * 2019-01-03 2019-05-07 北京蛋白质组研究中心 一种jmh血型抗原芯片及其在红细胞意外抗体检测中的应用
KR20220129585A (ko) 2020-01-24 2022-09-23 슬링샷 바이오사이언시즈 인코포레이티드 세포-유사 보정 입자를 위한 조성물 및 방법
FR3106900B1 (fr) * 2020-02-04 2024-10-04 Innobiochips Procédé de capture et d’identification d’agglutinats cellulaires pour la détection d’anticorps anti-érythrocytaires multiplexe
JP7807395B2 (ja) 2020-05-04 2026-01-27 スリングショット バイオサイエンシーズ， インコーポレイテッド 多重化アッセイのためのパッシブ光学バーコード付与のための組成物および方法
CN111662869A (zh) * 2020-06-02 2020-09-15 北京康思润业生物技术有限公司 用于分离红细胞的免疫磁珠及其制备方法和应用
WO2022005953A1 (en) * 2020-06-29 2022-01-06 Siemens Healthcare Diagnostics Inc. Devices and methods for plasma separation and metering
RU2020122142A (ru) * 2020-07-03 2022-01-04 Петр Иванович Никитин Композиция и способ для улучшения эффективности и снижения побочных эффектов терапевтического агента, доставляемого к мишени с помощью магнитного поля
AU2022376541A1 (en) 2021-10-29 2024-04-18 Slingshot Biosciences, Inc. Hydrogel particles as feeder cells and as synthetic antigen presenting cells
KR102609257B1 (ko) * 2021-11-10 2023-12-04 고대현 Abo 항체 검사 장치 및 그 검사 방법
CN114113639B (zh) * 2022-01-29 2022-04-19 北京大有天弘科技有限公司 一种血型抗体检测方法及其应用
CN114397464B (zh) * 2022-03-24 2022-06-10 天津德祥生物技术有限公司 一种红细胞膜碎片与载体的偶联复合物、其偶联方法和应用
CN119907921A (zh) 2022-05-05 2025-04-29 弹弓生物科学公司 用于血液学的作为红细胞模拟物的工程化颗粒和含有工程化颗粒的组合物
CA3257621A1 (en) 2022-06-02 2023-12-07 Slingshot Biosciences, Inc. APOPTOTIC CELL MIMETIC
CN120712108A (zh) 2022-10-26 2025-09-26 弹弓生物科学公司 具有可调整光学性质的大小可调整合成颗粒和用于使用其进行免疫细胞激活的方法
WO2025049609A1 (en) 2023-08-29 2025-03-06 Slingshot Biosciences, Inc. Cd34 stem cell mimics
CN120522400B (zh) * 2025-05-12 2026-03-31 陕西艾瑞万生物科技有限公司 一种红细胞同种抗体特异性分析方法及分析设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608246A (en) * 1983-03-10 1986-08-26 Immucor, Inc. Testing for a blood group immunological reaction
JPS6040958A (ja) * 1983-08-15 1985-03-04 Seitetsu Kagaku Co Ltd 血液型物質感作ゼオライト粒子
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
JP2532670B2 (ja) * 1988-07-20 1996-09-11 オリンパス光学工業株式会社 磁性マ―カ―粒子を用いた免疫学的測定方法
JPH02165052A (ja) * 1988-12-20 1990-06-26 Olympus Optical Co Ltd 免疫学的測定方法
US6933106B2 (en) * 1995-03-13 2005-08-23 Mark Hechinger Platelet immunoglobulin bead suspension and flow cytometry
JPH0954091A (ja) * 1995-08-09 1997-02-25 Nippon Zoki Pharmaceut Co Ltd 抗赤血球抗体の測定法
US5776711A (en) * 1996-11-12 1998-07-07 The Regents Of The University Of California Simultaneous human ABO and RH(D) blood typing or antibody screening by flow cytometry
US5948627A (en) * 1997-05-30 1999-09-07 One Lambda Immunobead flow cytometric detection of anti-HLA panel-reactive antibody
DE69812329T2 (de) 1997-11-18 2004-02-12 Bio-Rad Laboratories, Inc., Hercules Multiplex-zufluss-immunotest mit magnetischen teilchen als festphase
DE69830854T2 (de) * 1997-12-04 2006-04-20 Amersham Biosciences Uk Ltd., Amersham Mehrfaches testverfahren
JP4054500B2 (ja) * 1999-12-27 2008-02-27 オリンパス株式会社 抗原、抗体及びｄｎａ等の核酸を検出用のプローブとして用いた多項目検査方法
JP4410374B2 (ja) * 2000-03-31 2010-02-03 オリンパス株式会社 多項目生物試料検査方法
AU2003275940A1 (en) * 2002-10-31 2004-05-25 Chemometec A/S A method for assessment of particles
DE10330981B4 (de) * 2003-07-09 2010-04-01 Medion Diagnostics Ag Vorrichtung und Verfahren zur simultanen Durchführung von Blutgruppenbestimmung, Serumgegenprobe und Antikörpersuch-Test
TW200508609A (en) * 2003-07-15 2005-03-01 Bioarray Solutions Ltd Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays
GB0506183D0 (en) * 2005-03-24 2005-05-04 Univ Edinburgh Antigen detection
FR2917174B1 (fr) * 2007-06-08 2021-02-12 Bio Rad Pasteur Analyse multiple d'echantillons sanguins

Also Published As

Publication number Publication date
AU2008258505B2 (en) 2014-08-28
CN101715558A (zh) 2010-05-26
IL202216A (en) 2015-11-30
US20100178656A1 (en) 2010-07-15
EA017186B1 (ru) 2012-10-30
US8580531B2 (en) 2013-11-12
US20100184101A1 (en) 2010-07-22
MX2009013411A (es) 2010-04-09
JP2010529444A (ja) 2010-08-26
EP2158492B1 (en) 2018-11-28
AU2008258505A1 (en) 2008-12-11
KR101508699B1 (ko) 2015-04-08
AU2008258509A1 (en) 2008-12-11
KR101524107B1 (ko) 2015-05-29
MX2009013388A (es) 2010-04-09
BRPI0812770A2 (pt) 2014-12-02
EP2160609B1 (en) 2018-11-28
EP2158492A1 (en) 2010-03-03
JP5587179B2 (ja) 2014-09-10
EP2160609A1 (en) 2010-03-10
NZ581716A (en) 2012-11-30
NZ603084A (en) 2014-08-29
ZA201000095B (en) 2010-09-29
KR20100046138A (ko) 2010-05-06
JP5768371B2 (ja) 2015-08-26
US8580530B2 (en) 2013-11-12
FR2917174A1 (fr) 2008-12-12
CA2687829A1 (en) 2008-12-11
WO2008148886A1 (en) 2008-12-11
AU2008258509B2 (en) 2014-01-16
CN101711363A (zh) 2010-05-19
ZA201000093B (en) 2011-04-28
FR2917174B1 (fr) 2021-02-12
IL202216A0 (en) 2010-06-16
WO2008148890A1 (en) 2008-12-11
IL202322A0 (en) 2010-06-30
EA200971124A1 (ru) 2010-06-30
EA200971114A1 (ru) 2010-06-30
CA2687756A1 (en) 2008-12-11
EA017380B1 (ru) 2012-12-28
KR20100043180A (ko) 2010-04-28
JP2010529445A (ja) 2010-08-26
NZ581717A (en) 2012-03-30

Similar Documents

Publication Publication Date Title
BRPI0812772A2 (pt) Método in vitro para a identificação de moléculas antigênicas transportadas por eritrócitos e/ou anticorpos anti-eritrocitários de um indivíduo, método para combinação cruzada de eritrócitos que devem ser transfundidos em um paciente e um conjunto de reagentes para a execução do método de detecção .
BR112012003809A2 (pt) anticorpa monoclonal isolado ou porção de ligação a antígeno do mesmo, composição e, método para tratar câncer em um indivíduo.
BRPI0813645A2 (pt) Métodos para modificar anticorpos, e anticorpos modificados com propriedades funcionais aperfeiçoadas
CY1121536T1 (el) Ανθρωπινα αντισωματα εναντι-αλφα-συνουκλεϊνης
BRPI0813287A2 (pt) Planejamento e otimização baseados na sequência de anticorpos de cadeia única
BRPI0812657A2 (pt) "sistema para gerar, detectar e interpretar sinais acústicos em um sistema de poço e método para detectar e interpretar sinais acústicos em um sistema de poço"
BRPI0910375A2 (pt) "mecanismo e método para gerar sinais de saída de áudio usando metadados com base em objeto"
BRPI0819085A2 (pt) Sistema para uso com produção de hidrocarbonetos, e, método associado com produção de hidrocarbonetos
EP2193514A4 (en) Obstetrics simulation and training method and system
ECSP088733A (es) Anticuerpos anti-5t4 y usos de los mismos
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
BRPI0819338A2 (pt) Preparações, métodos e kits úteis para o tratamento de tosse
IL234081B (en) Cross - species - specific cd3 - epsilon binding antibody
EP2227767A4 (en) SYSTEM FOR OPTIMIZING THE TRANSPORT TERMINATION
EP2010659A4 (en) KITS AND METHOD FOR GENERATING RNA AT 5'-CAP STRUCTURE
CU20120095A7 (es) Antagonistas de pcsk9
WO2012009644A3 (en) Methods to identify synthetic and natural rna elements that enhance protein translation
BRPI0821334A2 (pt) método utilizável em um poço, e sistema utilizável com um poço.
BRPI0811799A2 (pt) "reagente para análise de leucócitos imaturos, kit de reagentes para análise de leucócitos imaturos e método para classificar leucócitos"
BRPI0914465A2 (pt) "método para buscar conteúdos multimídia na internet"
BRPI0812771A2 (pt) Método para a detecção e diagnóstico in vitro de uma infecção por um microorganismo, conjunto de reagentes para a realização do método de detecção .
BRPI1016065A2 (pt) "processo para detectar, de maneira quantitativa, uma proteína alvo em uma amostra."
BRPI0810243A2 (pt) Método e sistema implementado por processador, e meio acessível por processador para responder às pesquisas de seqüência de texto de usuário, e, aparelho para responder às pesquisas da seqüência de texto do usuário
BR112014011535A2 (pt) método para a determinação in vitro e imunológica de presença da presença e/ou da quantidade de um parceiro de ligação, método in vitro e utilização de um anticorpo
DK1976884T3 (da) Anti-ephrinb2-antistoffer og fremgangsmåder til anvendelse deraf.

Legal Events

Date Code Title Description
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: BIO-RAD PASTEUR (FR)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 20120003311/RJ, DE 13/01/2012, E NECESSARIO APRESENTAR O DOCUMENTO DEVIDAMENTE NOTARIZADO.

B25D Requested change of name of applicant approved

Owner name: BIO-RAD INNOVATIONS (FR)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]